Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients
Clinical trial NCT03419494 · UNKNOWN
Trial details
- NCT number
- NCT03419494
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-10-10
- Primary completion
- 2019-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.